News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Protalix Biotherapeutics and Secarna Pharmaceuticals Form Collaboration and Option Agreement
Thursday, December 18, 2025Protalix BioTherapeutics and Secarna Pharmaceuticals have entered into a collaboration and option agreement to develop new antisense oligonucleotide ASO therapies for rare kidney diseases
INCOG BioPharma Announces $200 Million Investment to Expand Operations and Grow Workforce to Nearly 1,000
Wednesday, December 17, 2025INCOG BioPharma Services has announced a further expansion with an investment of around million in its injectable drug manufacturing plant in Fishers Indiana The investment will significantly
Grifols secures full EMA approval for end-to-end Grifols Egypt plasma-derived medicines value chain to supply European markets
Tuesday, December 16, 2025Grifols has obtained European Medicines Agency approval for the entire Grifols Egypt plasmaderived medicines value chain strengthening its European supply strategy and manufacturing footprint
ENHERTU® Plus Pertuzumab Approved in the U.S. as First New First-Line Treatment in a Decade for HER2-Positive Metastatic Breast Cancer
Tuesday, December 16, 2025AstraZeneca and Daiichi Sankyo have received US approval for ENHERTU famtrastuzumab deruxtecannxki in combination with pertuzumab as a firstline treatment for adults with unresectable
Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion Therapy
Tuesday, December 16, 2025Dren Bio a privately held clinicalstage biotechnology company has expanded its strategic collaboration with Sanofi to discover and develop a nextgeneration Bcell depletion therapy for the treatment of autoimmune diseases
LEO Pharma Submits Label Expansion Application to EMA for Anzupgo in Adolescent Chronic Hand Eczema Patients
Monday, December 15, 2025LEO Pharma has submitted and received acceptance for a label expansion application to the European Medicines Agency for Anzupgo cream to include adolescent patients aged with moderate to severe chronic hand eczema
EU Lawmakers Agree Deal on Long-Awaited Pharma Reform Package
Friday, December 12, 2025EU lawmakers have reached an agreement on the longawaited pharmaceutical reform package balancing innovation incentives with patient access across Europe
EU institutions reach historic political agreement on major reform of pharmaceutical legislation
Thursday, December 11, 2025EU legislators have reached a political agreement on the first major overhaul of EU pharmaceutical legislation in years reshaping incentives market access and supply obligations for the European life sciences industry
FDA Grants Breakthrough Therapy Designation to Investigational Drug Adrabetadex for Infantile-Onset Niemann-Pick Disease Type C
Wednesday, December 10, 2025Beren Therapeutics through its subsidiary Mandos LLC has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for adrabetadex
Formycon and Zydus Sign Exclusive Licensing and Supply Agreement for FYB206, a Biosimilar to Keytruda®, in the U.S. and Canada
Wednesday, December 10, 2025Formycon AG and Zydus Lifesciences have entered into a strategic partnership covering the exclusive licensing and supply of FYB a biosimilar version of pembrolizumab Keytruda for the US and Canadian markets
